|
Name |
Pestalone
|
| Molecular Formula | C21H20Cl2O6 | |
| IUPAC Name* |
2-(3,5-dichloro-2-hydroxy-6-methoxy-4-methylbenzoyl)-4,6-dihydroxy-3-(3-methylbut-2-enyl)benzaldehyde
|
|
| SMILES |
CC1=C(C(=C(C(=C1Cl)OC)C(=O)C2=C(C(=CC(=C2C=O)O)O)CC=C(C)C)O)Cl
|
|
| InChI |
InChI=1S/C21H20Cl2O6/c1-9(2)5-6-11-13(25)7-14(26)12(8-24)15(11)19(27)16-20(28)17(22)10(3)18(23)21(16)29-4/h5,7-8,25-26,28H,6H2,1-4H3
|
|
| InChIKey |
ACRANQNXYMAQKJ-UHFFFAOYSA-N
|
|
| Synonyms |
Pestalone; Pestalon; CHEMBL489144; 2-(3,5-dichloro-2-hydroxy-6-methoxy-4-methylbenzoyl)-4,6-dihydroxy-3-(3-methylbut-2-enyl)benzaldehyde
|
|
| CAS | NA | |
| PubChem CID | 10071878 | |
| ChEMBL ID | CHEMBL489144 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 439.3 | ALogp: | 6.3 |
| HBD: | 3 | HBA: | 6 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 104.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 29 | QED Weighted: | 0.319 |
| Caco-2 Permeability: | -5.02 | MDCK Permeability: | 0.00001690 |
| Pgp-inhibitor: | 0.014 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.043 | 20% Bioavailability (F20%): | 0.003 |
| 30% Bioavailability (F30%): | 0.003 |
| Blood-Brain-Barrier Penetration (BBB): | 0.011 | Plasma Protein Binding (PPB): | 101.64% |
| Volume Distribution (VD): | 0.187 | Fu: | 0.85% |
| CYP1A2-inhibitor: | 0.783 | CYP1A2-substrate: | 0.851 |
| CYP2C19-inhibitor: | 0.239 | CYP2C19-substrate: | 0.124 |
| CYP2C9-inhibitor: | 0.899 | CYP2C9-substrate: | 0.899 |
| CYP2D6-inhibitor: | 0.486 | CYP2D6-substrate: | 0.205 |
| CYP3A4-inhibitor: | 0.228 | CYP3A4-substrate: | 0.178 |
| Clearance (CL): | 5.124 | Half-life (T1/2): | 0.095 |
| hERG Blockers: | 0.018 | Human Hepatotoxicity (H-HT): | 0.287 |
| Drug-inuced Liver Injury (DILI): | 0.94 | AMES Toxicity: | 0.498 |
| Rat Oral Acute Toxicity: | 0.111 | Maximum Recommended Daily Dose: | 0.941 |
| Skin Sensitization: | 0.573 | Carcinogencity: | 0.683 |
| Eye Corrosion: | 0.006 | Eye Irritation: | 0.946 |
| Respiratory Toxicity: | 0.358 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004842 | ![]() |
0.817 | D0WY9N | ![]() |
0.291 | ||
| ENC004838 | ![]() |
0.761 | D0Q0PR | ![]() |
0.266 | ||
| ENC004238 | ![]() |
0.744 | D04FBR | ![]() |
0.244 | ||
| ENC004233 | ![]() |
0.690 | D07MEH | ![]() |
0.236 | ||
| ENC004843 | ![]() |
0.593 | D0ZX2G | ![]() |
0.236 | ||
| ENC004839 | ![]() |
0.541 | D06GCK | ![]() |
0.229 | ||
| ENC004841 | ![]() |
0.526 | D05QDC | ![]() |
0.228 | ||
| ENC002644 | ![]() |
0.510 | D0WN0U | ![]() |
0.222 | ||
| ENC001395 | ![]() |
0.455 | D0B1IP | ![]() |
0.217 | ||
| ENC000921 | ![]() |
0.447 | D06JGH | ![]() |
0.216 | ||